Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1304850

registered interest
date	22/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of reducing the length of time between provision of first and second covid-19 vaccine doses to people deemed to be clinically immunocompromised.
tabling member constituency	Ealing Central and Acton
tabling member printed	Dr Rupa Huq
uin	173111
answer	answer is ministerial correction date of answer 07/04/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) advise Government on which vaccines the United Kingdom should use and provide advice on prioritisation, based on their assessments.</p><p>Recent assessment of the data available shows that the first dose of both vaccines currently deployed provides substantial protection within 2-3 weeks of vaccination from severe COVID-19 disease. The second vaccine dose is important to sustain the protection and extend its duration. In the short term however, the additional impact of the second dose is likely to be modest and most of the initial protection from clinical disease is after the first dose of vaccine. The four UK Chief Medical Officers agreed with the Joint Committee on Vaccination and Immunisation (JCVI) that prioritising the first doses of vaccine for as many people as possible on the priority list would protect the greatest number of at-risk people in the shortest possible time.</p><p>There are currently no plans to reduce the length of time between the provision of first and second COVID-19 doses for people deemed to be clinically immunocompromised.</p><p>The JCVI will continually monitor and assess vaccine effectiveness, including the protection afforded to specific patient groups, such as immunocompromised people, on an ongoing basis. If new evidence comes to light, the JCVI will review their policy to help better protect those most at risk of COVID-19 in the UK.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/04/2021 09:22:51 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 93538 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4511 label Biography information for Dr Rupa Huq

1304874

registered interest
date	22/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish an updated timetable for the estimated (a) regulatory approval and (b) delivery to the NHS of the (i) Novavax and (ii) Johnson & Johnson covid-19 vaccines; and if he will make a statement.
tabling member constituency	Wycombe
tabling member printed	Mr Steve Baker
uin	172997
answer	answer is ministerial correction date of answer 26/03/2021 answer text <p>Reviews are underway by the  Medicines and Healthcare products Regulatory Agency (MHRA) to assess the Johnson &amp; Johnson (known by Janssen in Europe) and Novavax vaccines. Any vaccines that are made available will have been authorised because they pass the MHRA’s tests on safety and efficacy. If and when those vaccines are authorised by the MHRA, we expect to receive the doses for both vaccines in the second half of this year.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/03/2021 15:00:23 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 93502 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4064 label Biography information for Mr Steve Baker

1304310

registered interest
date	19/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Joint Committee on Vaccination and Immunisation on moving people with chronic fatigue syndrome (CFS/ME) into priority group 6 for the covid-19 vaccine.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	172024
answer	answer is ministerial correction date of answer 25/03/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent body made up of scientific and clinical experts who advise the Government on which vaccines the United Kingdom should use and provide advice on prioritisation at a population level.</p><p>The JCVI’s advice is that to date, chronic fatigue syndrome or myalgic encephalomyelitis has not been identified as a condition that would place an individual at increased clinical risk to COVID-19 and therefore eligible for vaccination in priority group six. The JCVI’s advice is available at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020" target="_blank">www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020</a></p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 25/03/2021 15:10:18 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 93129 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1506 label Biography information for Andrew Gwynne

1304315

registered interest
date	19/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason people with chronic fatigue syndrome (CFS/ME) are being offered the covid-19 vaccine in some areas of the country and not in others.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	172025
answer	answer is ministerial correction date of answer 01/04/2021 answer text <p>To date, chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) has not been identified as a condition that makes an individual clinically extremely vulnerable to COVID-19 or would place an individual at increased clinical risk. It is likely that some people with CFS/ME are being offered vaccines because they are eligible through other means such as their age or they have other underlying health issues that would it put them at increased clinical risk.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 01/04/2021 12:28:56 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 93130 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1506 label Biography information for Andrew Gwynne

1304320

registered interest
date	19/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which age groups are planned to have received a covid-19 vaccine ahead of the FA Cup Final on 15 May 2021.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	172107
answer	answer is ministerial correction date of answer 25/03/2021 answer text <p>Whilst an exact timeline of which age groups are planned to have been offered a COVID-19 vaccine by 15 May 2021 is not available, we are on course to offer a vaccine to all priority groups including those aged 50 years old and over by 15 April and all adults aged 18 years old and over by 31 July.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 25/03/2021 14:42:39 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 93134 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4603 label Biography information for Preet Kaur Gill

1302467

registered interest
date	15/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of covid-19 vaccines administered to date were manufactured by Oxford Astra Zeneca; and what information his Department holds on the number of people who have received that vaccine who have since reported serious blood clotting.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	168843
answer	answer is ministerial correction date of answer 30/03/2021 answer text <p>As of 14 March, an estimated 13.7 million doses of the Oxford /AstraZeneca vaccine have been administered. As of the same date, the Medicines and Healthcare products Regulatory Agency (MHRA) has received 187 reports of blood clots reported in temporal association with the vaccine.</p><p>Such reports are not proven side effects of the vaccine. Blood clots can occur naturally and are not uncommon and this number is not greater than would have occurred naturally in the vaccinated population.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 30/03/2021 15:58:31 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 91634 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1409 label Biography information for Mr Gregory Campbell

1301312

registered interest
date	10/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to tackle vaccine hesitancy amongst homeless people.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	166586
answer	answer is ministerial correction date of answer 22/03/2021 answer text <p>On 11 March, the Joint Committee on Vaccination and Immunisation (JCVI) advised that local teams should consider a universal offer to adults experiencing homelessness and rough sleeping alongside those in priority group six. They advised that they should be offered the vaccine without the need for a National Health Service number or general practitioner registration.</p><p>Work is being undertaken to update our operational guidance on reaching rough sleepers and homeless people based on the JCVI’s most recent advice. The Ministry for Housing, Communities and Local Government is working closely with NHS England and NHS Improvement to support outreach services and further work is being done to explore the availability of effective on-street models which could be used to support this work.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/03/2021 12:07:31 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 90295 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4811 label Biography information for Navendu Mishra

1301313

registered interest
date	10/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of homeless people that have been vaccinated up to 10 March 2021.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	166587
answer	answer is ministerial correction date of answer 15/03/2021 answer text <p>The information is not collected in the format requested therefore no specific estimate has been made.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/03/2021 17:00:48 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 90276 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4811 label Biography information for Navendu Mishra

1300773

registered interest
date	09/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that all people who are not registered with a GP who are eligible for the covid-19 vaccine are (a) identified and (b) contacted to access that vaccine.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	165581
answer	answer is ministerial correction date of answer 12/03/2021 answer text <p>The terms under which general practitioner (GP) practices are commissioned to deliver the COVID-19 vaccination services enable practices to vaccinate unregistered patients. Individuals who are not registered with a GP will therefore be able to access the vaccine in line with the priority groups outlined by the Joint Committee on Vaccination and Immunisations (JCVI). However, we would strongly encourage everyone to register so that they may be more easily invited for vaccination.</p><p>Every local system should have a plan for full coverage for inclusion health groups - for example, homeless people. NHS England and NHS Improvement are working with local government, voluntary, community and social enterprise partners and Healthwatch England on a campaign to support all people, particularly those in inclusion health groups, to register with a GP. A key driver of the registration campaign is to support identification of those who should be prioritised for the vaccine.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/03/2021 15:30:49 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 89970 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4418 label Biography information for Justin Madders

1299927

registered interest
date	05/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of using serology testing to establish the length of protection provided by covid-19 vaccines.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	163665
answer	answer is ministerial correction date of answer 22/03/2021 answer text <p>Public Health England (PHE) is evaluating the effectiveness and length of protection afforded by COVID-19 vaccines in terms of disease, hospitalisations and deaths as set out in the COVID-19 vaccine surveillance strategy.</p><p> </p><p>Although serological testing is supporting the evaluation of COVID-19 vaccines, currently without a correlate of protection, serological testing by itself cannot provide estimates of the length of protection from COVID-19 vaccines.</p><p> </p><p>PHE’s SIREN study, a prospective cohort study of almost 40,000 healthcare workers from 132 National Health Service sites, collects regular serum samples on participants following COVID-19 vaccination, to monitor antibody responses to vaccination which has the potential to establish a serological correlate of protection.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/03/2021 17:16:31 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 89253 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1604 label Biography information for Mr Virendra Sharma